Introduction
Anxiolytics and hypnotics (AX-HY) are the most commonly used psychotropic drugs in Europe in general and especially in France, where the annual prevalence rate of its use in 2000 (19%) was nearly double that the average of other European countries (10%) [1] [2] [3] . In France, these drugs are mainly prescribed by general practitioners (GPs) [4] and are often prescribed or used inappropriately: treatment often does not match the patient's actual diagnosis [3] , and the length of treatment often exceeds recommended durations. Indeed, about 5% of the French population uses AX-HY chronically [3, 5] . These reports are particularly worrisome since benzodiazepines may cause dependence and side effects [6] [7] [8] [9] [10] [11] .
AX-HY use varies between French administrative regions, ranging from 16% to 21% for AX and from 8% to 12% for HY [12, 13] . Such geographic differences are of concern to policy-makers since they may represent either excessive levels of unnecessary care or undertreatment, perhaps due to difficulties in access to health services. Priority areas for intervention could be better identified if these variations were better described and their determinants more completely understood [14] [15] [16] . To the best of our knowledge, few studies have focused on geographic variations of AX-HY use and its determinants, except for one study in France [13] and another in Northern Ireland [17] . The latter showed that geographic variations in the prevalence of benzodiazepines use were highly associated with the proportions of elderly people and of women in the area [17] .
Studies of geographic variations in utilization of other mental health services or drugs (e.g., acute psychiatric admissions, psychostimulants, antidepressants, and opioid analgesics) suggest that several factors besides demography may explain them. Specifically, they include social factors, such as poverty, socioeconomic deprivation, social fragmentation, individual isolation, and concentration of minority ethnic groups [18] [19] [20] [21] , as well as the supply and geographic proximity of health care services [18, 19, 22] . As far as we know, the prevalence of chronic diseases has not been taken into account in previous published articles analysing AX-HY use geographic variations, although epidemiological evidence shows substantial comorbidity between chronic physical diseases and mental disorders [23] .
In this article, we use the reimbursement database of the southeastern France regional health insurance fund (PACA-CNAMTS) to: 1) describe geographic variations of the prevalence of AX-HY dispensing at a canton level, and 2) identify canton characteristics (demographic and socioeconomic factors, GP density, prevalence of chronic illnesses) associated with the prevalence of AX-HY dispensing.
Materials and methods

Data on dispensing of anxiolytics and hypnotics
As in other French studies of psychotropic drug use [13, 24, 25] , data came from the outpatient reimbursement database of the general health insurance fund of southeastern France (PACA-CNAMTS). This fund covers salaried employees in trade and industry, who account for more than 70% of the population in France as a whole and in southeastern France in particular [26] .
This database includes all instances in which prescribed drugs were dispensed by community pharmacies. It does not include any prescriptions dispensed by public hospital pharmacies. Each time a prescribed drug is dispensed by a community pharmacy, information on the drug dispensed (barcode) and the patient identification number (by means of a "smart" or chip card issued by the health insurance authorities) are recorded and electronically sent to the general health insurance fund. Pharmacies may not give the patient treatment for more than one month at a time. Physicians can prescribe a treatment for a longer duration, if they so specify on the prescription. In that case, patient must come back each month to the pharmacy with the prescription to get a one-month treatment (prescription refills). gender, five-year age group (from 0-4 to 95 years or older), and code of the canton of residence. We also knew if subjects were covered by the public supplementary health insurance program ("CMUC") or were exempt from copayments because of a long-term illness (the "ALD" program providing 100% reimbursement for chronic or long-term disease).
For each canton, we calculated the 2005 period prevalence of AX-HY dispensing as the ratio of individuals with at least one delivery of an AX or HY in 2005 (regardless of the location of the pharmacy or of the prescriber) to the number of people covered by the general health insurance fund and residing in that canton at the end of 2005. We also calculated the prevalence of patients who received an AX or HY at least six times, used as a proxy for chronic use [3] . Age-adjusted prevalence was calculated for men and women separately with the direct standardisation method and with the most recent census data (1999) for the French population as the reference (five-year age groups).
Unit of analysis
Cantons were chosen as the geographic units for this analysis because they were the smallest units for which individual-level health insurance data were available that ensured subjects' anonymity. A French canton is a subdivision of a district 
Explanatory variables
We defined explanatory variables on the basis of aggregate data at canton level, derived from different sources. To assess mental illness, we determined age-adjusted proportions of subjects with at least one filled prescription for an antipsychotic agent (N05A1-N05A9 according to the EphMRA classification) in 2005 and used it as a proxy for the prevalence of severe mental illness [30, 31] . Antipsychotics are prescribed not only for psychotic patients, but also frequently for patients with major depression, anxiety, and dementia [32] . Thus the prevalence of antipsychotic use should not be interpreted as a proxy for psychotic diseases specifically.
Statistical analysis
We calculated descriptive statistics of the variation in the prevalence of AX-HY deliveries according to age and gender. We also calculated the Pearson correlation coefficient between the global prevalence of AX-HY use and of chronic use.
At the canton level, all prevalence rates are reported with their 95% confidence intervals [33] . These intervals were not calculated at the regional level because the numerators and denominators were so high.
We measured variation between cantons with the extremal quotient (EQ) and the weighted coefficient of variation (COV), two statistics often used in small-area analyses [27] . The EQ is the ratio of the highest rate to the lower rate. The weighted COV is the ratio of the standard deviation of the rates (among cantons) to the mean rate (among cantons) weighted by the population in each canton. We 
Results
Descriptive results
Of the 4,406,046 people included in the regional health insurance database, 
Factors associated with the prevalence of AX-HY use by cantons
Among women, the prevalence of subjects with chronic illness and of people using antipsychotics, unemployment rates, mean family income, and the percentage of subsidized housing were each positively and independently associated with the prevalence of AX-HY dispensing (Table I) . The results were similar for men, except that the significant association with subsidized housing rate disappeared (Table II) . 'R²' was 0.497 for women and 0.533 for men.
The prevalence of chronic use of AX-HY among women at the canton level was strongly and positively associated with the prevalence of antipsychotic use and of subjects with chronic illness, the proportion of the population aged 45-59 years, and the proportion of subsidized housing. It was negatively associated with the proportion of inadequate housing and of the population aged 60-74 years (Table   I ). Among men, it was also positively associated with the prevalence of antipsychotic use and of subjects with chronic illnesses, but not with the proportion of subsidized housing. As among women, it was also negatively associated with the percentage of inadequate housing (Table II) . 'R²' was 0.518 for women and 0.474 for men.
Discussion
Our results confirm the high prevalence of AX-HY use in southeastern France:
15.5% of the population had a prescription for AX-HY filled at least once in 2005.
We cannot rule out the possibility that the true proportion of AX-HY users is slightly higher than our results since a small proportion of AX-HY might have been delivered without medical prescription. The proportion we found in our study is slightly lower than that observed in 2000 from the same source [13] Finally, the prevalence of chronic AX-HY use in our study was strongly associated with the prevalences of antipsychotic use and chronic morbidity.
Contrary to overall use prevalence, it was not associated with unemployment rates or income levels. This is consistent with previous results showing that factors associated with long-term use of AX-HY differ from those associated with any use [59] . Age, disability, and mental and somatic illnesses appear to be the strongest determinants of chronic benzodiazepine use [67] [68] [69] .
Like other studies analyzing pharmaceutical reimbursement data, our study has some limitations. It is based on the database of the French general health insurance fund, which does not cover farmers, tradespeople, shopkeepers, professional occupations and other self-employed workers. As far as we know, little information is available on psychotropic drug use in these groups. One study observed a higher annual prevalence of AX-HY use among general practitioners  classified as self-employed workers  than in the general population [70] .
However, evidence on the association between AX-HY use and socioeconomic groups remains still contradictory [56] [57] [58] [59] [60] . Consequently, our results cannot be considered as representative of the regional population as a whole.
The database does not include reimbursements for drugs dispensed by public hospitals. A study of 91 hospitalized patients showed that 46% of them had been prescribed an AX or HY during their hospitalization [71] . GPs often, however, continue AX or HY treatment initially prescribed in hospitals.
Moreover, data from the health fund database do not provide information about the medical reasons for prescriptions, or about whether purchasers take the drugs as prescribed or at all. 
